{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:16:15Z","timestamp":1790630175626,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000233","name":"Genome British Columbia","doi-asserted-by":"publisher","award":["SIP007"],"award-info":[{"award-number":["SIP007"]}],"id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008154","name":"Canadian Allergy, Asthma and Immunology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011775","name":"BC Children\u2019s Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.coi.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T03:17:33Z","timestamp":1615519053000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Human MALT1 deficiency and predisposition to infections"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-7748","authenticated-orcid":false,"given":"Henry Y","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart E","family":"Turvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2021.02.008_sbref0005","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3389\/fimmu.2018.01927","article-title":"Holding all the CARDs: how MALT1 controls CARMA\/CARD-dependent signaling","volume":"9","author":"Juilland","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.02.008_sbref0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-018-0087-2","article-title":"CARD-BCL-10-MALT1 signalling in protective and pathological immunity","volume":"19","author":"Ruland","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaci.2013.04.047","article-title":"A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency","volume":"132","author":"Jabara","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_sbref0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10875-019-00629-0","article-title":"Novel MALT1 mutation linked to immunodeficiency, immune dysregulation, and an abnormal T cell receptor repertoire","volume":"39","author":"Frizinsky","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_sbref0025","first-page":"202","article-title":"Refining the dermatological spectrum in primary immunodeficiency: mucosa-associated lymphoid tissue lymphoma translocation protein 1 deficiency mimicking Netherton\/Omenn syndromes","volume":"182","author":"Wiegmann","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2021.02.008_sbref0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaci.2020.07.034","article-title":"Human immune disorder associated with homozygous hypomorphic mutation affecting MALT1B splice variant","volume":"147","author":"Kutukculer","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0035","first-page":"47","article-title":"Case report: MALT1 mutation in a patient with severe combined immunodeficiency","volume":"3","author":"Shirmast","year":"2020","journal-title":"Immunol Genet J"},{"key":"10.1016\/j.coi.2021.02.008_bib0040","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jaci.2013.10.045","article-title":"Combined immunodeficiency associated with homozygous MALT1 mutations","volume":"133","author":"McKinnon","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10875-014-0125-1","article-title":"Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation","volume":"35","author":"Punwani","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MPG.0000000000001262","article-title":"Deficiency in mucosa-associated lymphoid tissue lymphoma translocation 1: a novel cause of IPEX-like syndrome","volume":"64","author":"Charbit-Henrion","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coi.2021.02.008_sbref0055","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3389\/fimmu.2018.02078","article-title":"The CBM-opathies-A rapidly expanding spectrum of human inborn errors of immunity caused by mutations in the CARD11-BCL10-MALT1 complex","volume":"9","author":"Lu","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.02.008_sbref0060","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.jaci.2019.03.009","article-title":"Germline CBM-opathies: from immunodeficiency to atopy","volume":"143","author":"Lu","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0065","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","article-title":"The role of nasal carriage in Staphylococcus aureus infections","volume":"5","author":"Wertheim","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2021.02.008_bib0070","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.02.008_sbref0075","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00439-020-02111-z","article-title":"The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity","volume":"139","author":"Boisson","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2021.02.008_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOH.0b013e32831952de","article-title":"Genetic and molecular diagnosis of severe congenital neutropenia","volume":"16","author":"Ward","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.coi.2021.02.008_bib0085","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CMR.00001-11","article-title":"Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency","volume":"24","author":"Picard","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coi.2021.02.008_bib0090","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2017.01.039","article-title":"Human adaptive immunity rescues an inborn error of innate immunity","volume":"168","author":"Israel","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coi.2021.02.008_bib0095","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.02.008_bib0100","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat4956","article-title":"A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity","volume":"3","author":"Beziat","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0105","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat4941","article-title":"ZNF341 controls STAT3 expression and thereby immunocompetence","volume":"3","author":"Frey-Jakobs","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0110","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.02.008_bib0115","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00439-020-02141-7","article-title":"Human inborn errors of immunity underlying superficial or invasive candidiasis","volume":"139","author":"Puel","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2021.02.008_bib0120","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.4049\/jimmunol.1701574","article-title":"Innate immunity to Staphylococcus aureus: evolving paradigms in soft tissue and invasive infections","volume":"200","author":"Brandt","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0125","first-page":"1","article-title":"Myeloid innate signaling pathway regulation by MALT1 paracaspase activity","author":"Unterreiner","year":"2019","journal-title":"J Vis Exp"},{"key":"10.1016\/j.coi.2021.02.008_bib0130","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.15252\/embj.201488987","article-title":"Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity","volume":"33","author":"Jaworski","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2021.02.008_bib0135","article-title":"MALT1 protease activity is required for innate and adaptive immune responses","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2021.02.008_bib0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOH.0000000000000206","article-title":"Signal transducer and activator of transcription 3: a year in review","volume":"23","author":"Forbes","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.coi.2021.02.008_bib0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00335-018-9767-2","article-title":"Human hyper-IgE syndrome: singular or plural?","volume":"29","author":"Zhang","year":"2018","journal-title":"Mamm Genome"},{"key":"10.1016\/j.coi.2021.02.008_bib0150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.02.008_bib0155","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.02.008_bib0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chom.2012.04.008","article-title":"Th17 cells in immunity to Candida albicans","volume":"11","author":"Hernandez-Santos","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2021.02.008_bib0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.02.008_bib0170","doi-asserted-by":"crossref","first-page":"E8277","DOI":"10.1073\/pnas.1618300114","article-title":"Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency","volume":"113","author":"Levy","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.02.008_bib0175","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.immuni.2013.09.002","article-title":"An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis","volume":"39","author":"Boisson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.02.008_bib0180","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax7965","article-title":"Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A\/F and TGF-beta","volume":"4","author":"Li","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0185","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.4049\/jimmunol.1402254","article-title":"Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation","volume":"194","author":"Bornancin","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001259","article-title":"Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2","volume":"7","author":"Gringhuis","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2021.02.008_bib0195","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/onc.2015.146","article-title":"MALT1 is required for EGFR-induced NF-kappaB activation and contributes to EGFR-driven lung cancer progression","volume":"35","author":"Pan","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.coi.2021.02.008_bib0200","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ni.3008","article-title":"Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation","volume":"15","author":"Jeltsch","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0205","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1172\/JCI63528","article-title":"The NF-kappaB regulator MALT1 determines the encephalitogenic potential of Th17 cells","volume":"122","author":"Brustle","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.02.008_bib0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00011-018-1207-y","article-title":"Malt1 inactivation attenuates experimental colitis through the regulation of Th17 and Th1\/17 cells","volume":"68","author":"Nakamura","year":"2019","journal-title":"Inflamm Res"},{"key":"10.1016\/j.coi.2021.02.008_sbref0215","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jid.2018.03.1503","article-title":"A CARD10-dependent tonic signalosome activates MALT1 paracaspase and regulates IL-17\/TNF-alpha-driven keratinocyte inflammation","volume":"138","author":"Israel","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2021.02.008_bib0220","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3389\/fimmu.2019.01107","article-title":"Immune control by TRAF6-mediated pathways of epithelial cells in the EIME (epithelial immune microenvironment)","volume":"10","author":"Dainichi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.immuni.2018.05.012","article-title":"Gain-of-function mutation of Card14 leads to spontaneous psoriasis-like skin inflammation through enhanced keratinocyte response to IL-17A","volume":"49","author":"Wang","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.02.008_bib0230","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1074-7613(03)00293-0","article-title":"Differential requirement for Malt1 in T and B cell antigen receptor signaling","volume":"19","author":"Ruland","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.02.008_bib0235","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/emboj.2011.85","article-title":"T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1","volume":"30","author":"Staal","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2021.02.008_bib0240","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jim.2014.04.007","article-title":"Mouse models for infectious diseases caused by Staphylococcus aureus","volume":"410","author":"Kim","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.coi.2021.02.008_bib0245","doi-asserted-by":"crossref","first-page":"19.6.1","DOI":"10.1002\/0471142735.im1906s105","article-title":"Animal models for candidiasis","volume":"105","author":"Conti","year":"2014","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0250","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fimmu.2020.00745","article-title":"Pharmacological inhibition of MALT1 protease leads to a progressive IPEX-Like pathology","volume":"11","author":"Martin","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and keratinocytes in psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2021.02.008_bib0260","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coi.2021.02.008_bib0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldz031","article-title":"Advances in the treatment of cytomegalovirus","volume":"131","author":"Krishna","year":"2019","journal-title":"Br Med Bull"},{"key":"10.1016\/j.coi.2021.02.008_bib0270","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2017.00665","article-title":"Recurrent and sustained viral infections in primary immunodeficiencies","volume":"8","author":"Ruffner","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0275","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaci.2018.07.013","article-title":"Lessons learned from the study of human inborn errors of innate immunity","volume":"143","author":"Bucciol","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0280","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood-2007-11-123513","article-title":"Multiple ITAM-coupled NK-cell receptors engage the Bcl10\/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production","volume":"112","author":"Gross","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.02.008_bib0285","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1002\/cpim.51","article-title":"Cytomegalovirus infection: mouse model","volume":"122","author":"Brizic","year":"2018","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0290","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2021.02.008_bib0295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.coi.2019.06.002","article-title":"Gene-environment interactions in primary atopic disorders","volume":"60","author":"Sacco","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0300","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2006.12.645","article-title":"Skin inflammation in RelB(-\/-) mice leads to defective immunity and impaired clearance of vaccinia virus","volume":"119","author":"Freyschmidt","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0305","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/BJ20120035","article-title":"Mechanism and specificity of the human paracaspase MALT1","volume":"443","author":"Hachmann","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.coi.2021.02.008_bib0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103774","article-title":"MALT1 auto-proteolysis is essential for NF-kappaB-dependent gene transcription in activated lymphocytes","volume":"9","author":"Baens","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2021.02.008_bib0315","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni1568","article-title":"The proteolytic activity of the paracaspase MALT1 is key in T cell activation","volume":"9","author":"Rebeaud","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0320","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ni1561","article-title":"T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20","volume":"9","author":"Coornaert","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0325","doi-asserted-by":"crossref","first-page":"14596","DOI":"10.1073\/pnas.1105020108","article-title":"Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines","volume":"108","author":"Hailfinger","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2021.02.008_bib0330","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.1038\/ncomms9777","article-title":"The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-kappaB signalling","volume":"6","author":"Klein","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2021.02.008_bib0335","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1111\/febs.13325","article-title":"MALT1\u2014a universal soldier: multiple strategies to ensure NF-kappaB activation and target gene expression","volume":"282","author":"Afonina","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.coi.2021.02.008_bib0340","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1242\/jcs.185025","article-title":"The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling","volume":"129","author":"Douanne","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.coi.2021.02.008_bib0345","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2013.04.034","article-title":"Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation","volume":"153","author":"Uehata","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.coi.2021.02.008_bib0350","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41564-019-0460-3","article-title":"N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation","volume":"4","author":"Yamasoba","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coi.2021.02.008_bib0355","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1198946","article-title":"Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation","volume":"331","author":"Rosebeck","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.02.008_bib0360","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1038\/ncomms6908","article-title":"Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma","volume":"6","author":"Nie","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2021.02.008_bib0365","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molmed.2015.12.004","article-title":"Targeting MALT1 proteolytic activity in immunity, inflammation and disease: good or bad?","volume":"22","author":"Demeyer","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.coi.2021.02.008_bib0370","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.celrep.2014.10.044","article-title":"Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation","volume":"9","author":"Gewies","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2021.02.008_bib0375","doi-asserted-by":"crossref","first-page":"914","DOI":"10.15252\/embr.201642109","article-title":"The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes","volume":"17","author":"Afonina","year":"2016","journal-title":"EMBO Rep"},{"key":"10.1016\/j.coi.2021.02.008_bib0380","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jid.2015.12.027","article-title":"MALT1 protease activity controls the expression of inflammatory genes in keratinocytes upon zymosan stimulation","volume":"136","author":"Schmitt","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2021.02.008_bib0385","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4049\/jimmunol.2001031","article-title":"Intrinsic abnormalities of keratinocytes initiate skin inflammation through the IL-23\/T17 axis in a MALT1-dependent manner","volume":"206","author":"Zhang","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0390","article-title":"Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-kappaB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells","volume":"13","author":"Wu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2021.02.008_bib0395","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/eji.201847597","article-title":"Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice","volume":"48","author":"Baens","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0400","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41586-020-2796-5","article-title":"Integration of innate immune signalling by caspase-8 cleavage of N4BP1","volume":"587","author":"Gitlin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.02.008_bib0405","article-title":"N4BP1 negatively regulates NF-\u03baB by binding and inhibiting NEMO oligomerization","volume":"12","author":"Shi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2021.02.008_bib0410","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","article-title":"Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation","volume":"40","author":"Nakaya","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.02.008_bib0415","doi-asserted-by":"crossref","first-page":"ra55","DOI":"10.1126\/scisignal.2005169","article-title":"T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10","volume":"7","author":"Hamilton","year":"2014","journal-title":"Sci Signal"},{"key":"10.1016\/j.coi.2021.02.008_bib0420","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ng.3898","article-title":"Germline hypomorphic CARD11 mutations in severe atopic disease","volume":"49","author":"Ma","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2021.02.008_bib0425","doi-asserted-by":"crossref","first-page":"e49237","DOI":"10.15252\/embr.201949237","article-title":"MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice","volume":"21","author":"Van Nuffel","year":"2020","journal-title":"EMBO Rep"},{"key":"10.1016\/j.coi.2021.02.008_bib0430","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2018.08.013","article-title":"Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease","volume":"143","author":"Dorjbal","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0435","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2213-2600(15)00202-7","article-title":"Lung disease in primary antibody deficiency","volume":"3","author":"Verma","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.coi.2021.02.008_bib0440","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1172\/JCI77493","article-title":"Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity","volume":"124","author":"Torres","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.02.008_bib0445","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10875-020-00760-3","article-title":"Human BCL10 deficiency due to homozygosity for a rare allele","volume":"40","author":"Van Den Rym","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0450","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2018.09.002","article-title":"Loss-of-function mutations in caspase recruitment domain-containing protein 14 (CARD14) are associated with a severe variant of atopic dermatitis","volume":"143","author":"Peled","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0455","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10875-018-0539-2","article-title":"Inherited CARD9 deficiency: invasive disease caused by ascomycete fungi in previously healthy children and adults","volume":"38","author":"Corvilain","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0460","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature04926","article-title":"Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity","volume":"442","author":"Gross","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.02.008_bib0465","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41590-018-0112-4","article-title":"CARD9(S12N) facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses","volume":"19","author":"Xu","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0470","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41590-019-0377-2","article-title":"CARD9(+) microglia promote antifungal immunity via IL-1beta- and CXCL1-mediated neutrophil recruitment","volume":"20","author":"Drummond","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.02.008_bib0475","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1215-2","article-title":"Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy","volume":"570","author":"Di Pilato","year":"2019","journal-title":"Nature"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:46:01Z","timestamp":1760604361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791521000182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":95,"alternative-id":["S0952791521000182"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2021.02.008","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human MALT1 deficiency and predisposition to infections","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}